Literature DB >> 16142568

Tamoxifen in the treatment of idiopathic retroperitoneal fibrosis.

Ihsan Ergun1, Kenan Keven, Basol Canbakan, Yakup Ekmekci, Bulent Erbay.   

Abstract

Idiopathic retroperitoneal fibrosis (RF) is a histologically benign, nonspecific inflammatory process of the fibroadipose tissue in the retroperitoneum with an unknown etiology. It may be complicated due to encasement and obstruction of the retroperitoneal structures. Tamoxifen has been known to be an effective agent in regression of desmoid tumors which include similar mesenchymal elements to those seen in RF. Herein, we reported a case of RF presented with ureteral obstruction and acute renal failure. The patient was successfully treated with tamoxifen.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16142568     DOI: 10.1007/s11255-004-0013-3

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  8 in total

1.  Surgery for idiopathic retroperitoneal fibrosis by ureterolysis and ureteric protection with a posterior pre-peritoneal fat flap.

Authors:  Cristóbal García Peñalver; A Tejido Sánchez; A Suárez Charneco; R Díaz González; A Rosino Sánchez; O Leiva Galvis
Journal:  BJU Int       Date:  2002-05       Impact factor: 5.588

2.  Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases.

Authors:  Renzo Marcolongo; Ivan Matteo Tavolini; Francesco Laveder; Moira Busa; Franco Noventa; Pierfrancesco Bassi; Gianpietro Semenzato
Journal:  Am J Med       Date:  2004-02-01       Impact factor: 4.965

3.  Bilateral ureteral obstruction due to envelopment and compression by an inflammatory retroperitoneal process.

Authors:  J K ORMOND
Journal:  J Urol       Date:  1948-06       Impact factor: 7.450

4.  Idiopathic retroperitoneal fibrosis treated with tamoxifen only.

Authors:  D al-Musawi; P Mitchenere; M al-Akraa
Journal:  Br J Urol       Date:  1998-09

5.  Treatment of idiopathic retroperitoneal fibrosis with tamoxifen.

Authors:  R Bourouma; D Chevet; F Michel; J P Cercueil; L Arnould; G Rifle
Journal:  Nephrol Dial Transplant       Date:  1997-11       Impact factor: 5.992

Review 6.  Retroperitoneal fibrosis. A true connective tissue disease.

Authors:  G S Gilkeson; N B Allen
Journal:  Rheum Dis Clin North Am       Date:  1996-02       Impact factor: 2.670

7.  Response of multicentric desmoid tumours to tamoxifen.

Authors:  H Procter; L Singh; M Baum; D Brinkley
Journal:  Br J Surg       Date:  1987-05       Impact factor: 6.939

8.  The long-term follow-up of idiopathic retroperitoneal fibrosis.

Authors:  R C Tiptaft; A J Costello; A M Paris; J P Blandy
Journal:  Br J Urol       Date:  1982-12
  8 in total
  3 in total

1.  Idiopathic retroperitoneal fibrosis: an unusual cause of low back pain.

Authors:  Petr Nemec; Sylva Rybnickova; Pavel Fabian; Zdenek Fojtik; Miroslav Soucek
Journal:  Clin Rheumatol       Date:  2007-10-11       Impact factor: 2.980

2.  Sclerosing mesenteritis as a cause of abdominal mass and discomfort in an elderly patient: a case report and literature review.

Authors:  Farzana Nawaz Ali; Sidra Ishaque; Bushra Jamil; Muhammad Idris
Journal:  Case Rep Med       Date:  2010-06-29

3.  Tamoxifen reduces silicone implant capsule formation in a mouse model.

Authors:  Kevin M Blum; Gabriel J M Mirhaidari; Jacob C Zbinden; Christopher K Breuer; Jenny C Barker
Journal:  FASEB Bioadv       Date:  2022-08-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.